14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 2 days ( 0 % )
Last Price $0.198 0 %
High/ Low $0.198 - $0.198 10.84%
Chg 7 Days 12.16 % $0.176 $0.198
Chg 30 Days -13.96 % $0.230 $0.198
Chg 12 mos -43.44 % $0.350 $0.198
Trend - 3 mos -49.11 % Width: 262.54 %
Trend - 12 mos -16.88 % Width: 256.10 %
Pred. range - 3 mos $0.0295 - $0.107 -85.08 % - -45.92 %
Pred. range - 12 mos $0.0881 - $0.314 -55.47 % - 58.56 %
Short MA avg 3 mos Buy Apr 15, 2024 - 9 days
Long MA avg 3 mos Sell Mar 25, 2024 - 22 days
Short/Long MA avg 3 mos Sell Feb 09, 2024 - 52 days
Short MA avg 12 mos Buy Apr 18, 2024 - 6 days
Long MA avg 12 mos Sell Feb 26, 2024 - 42 days
Short/Long MA avg 12 mos Sell Mar 01, 2024 - 38 days
Pivot Short Sell Apr 24, 2024 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About ImmunoCellular Therapeutics Ltd

ImmunoCellular Therapeutics  Ltd Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also dev... IMUC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT